U.S., Jan. 30 -- ClinicalTrials.gov registry received information related to the study (NCT06799715) titled 'Assessments of Metabolic Responses to Acute Oral Administration of Sucrose, Glucose, and Fructose' on Jan. 23.
Brief Summary: This project aims to compare the acute metabolic effects of the three sweeteners sucrose, glucose, and fructose on GI hormones (GLP-1, PYY, CCK, and ghrelin).
Furthermore, glycemic control, erythritol and xylitol concentrations, blood coagulation function , blood lipids, uric acid, high-sensitive C-reactive protein (hsCRP), complete blood count, gastric emptying, appetite-related sensations, and GI symptoms will be investigated.
Study Start Date: Feb., 2025
Study Type: INTERVENTIONAL
Condition:
Gastroint...